Hackett CJ[au] - Search Results

Year	Number of Results
1946	2
1949	1
1950	1
1951	1
1952	1
1953	6
1954	1
1956	2
1957	2
1958	2
1959	1
1960	3
1963	1
1970	1
1975	1
1976	1
1978	1
1979	1
1980	3
1981	3
1982	5
1983	2
1984	2
1985	3
1987	1
1988	2
1989	3
1990	2
1991	3
1992	1
1994	1
1995	1
1996	2
1999	1
2000	1
2002	2
2003	2
2005	1
2007	1
2008	1
2011	1
2013	1
2014	1
2021	0

1

Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?

Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, Gellin BG, Landry S. Offit PA, et al. Among authors: hackett cj. Pediatrics. 2002 Jan;109(1):124-9. doi: 10.1542/peds.109.1.124. Pediatrics. 2002. PMID: 11773551 Review.

2

Rationally-designed vaccine adjuvants: separating efficacy from toxicity.

Hauguel TM, Hackett CJ. Hauguel TM, et al. Among authors: hackett cj. Front Biosci. 2008 Jan 1;13:2806-13. doi: 10.2741/2887. Front Biosci. 2008. PMID: 17981755 Review.

3

Alloimmunization as a strategy for vaccine design against HIV/AIDS.

Lehner T, Shearer GM, Hackett CJ, Schultz A, Sharma OK. Lehner T, et al. Among authors: hackett cj. AIDS Res Hum Retroviruses. 2000 Mar 1;16(4):309-13. doi: 10.1089/088922200309188. AIDS Res Hum Retroviruses. 2000. PMID: 10716368 Review. No abstract available.

4

Addressing parents' concerns: do vaccines cause allergic or autoimmune diseases?

Offit PA, Hackett CJ. Offit PA, et al. Among authors: hackett cj. Pediatrics. 2003 Mar;111(3):653-9. doi: 10.1542/peds.111.3.653. Pediatrics. 2003. PMID: 12612250 Review.

5

McLetchie on mass campaigns.

Hackett CJ. Hackett CJ. Trop Doct. 1982 Jan;12(1):35-8. doi: 10.1177/004947558201200113. Trop Doct. 1982. PMID: 7041374

6

Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges.

Hackett CJ. Hackett CJ. J Allergy Clin Immunol. 2003 Oct;112(4):686-94. doi: 10.1016/s0091-6749(03)02025-6. J Allergy Clin Immunol. 2003. PMID: 14564345 Free PMC article. Review.

7

Hilary Koprowski and the viral immunity hub at the 1980s Wistar Institute: a T cell epitope perspective.

Hackett CJ. Hackett CJ. Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):177-8. doi: 10.1089/mab.2013.0091. Epub 2014 Jun 3. Monoclon Antib Immunodiagn Immunother. 2014. PMID: 24892373 Free PMC article. No abstract available.

8

Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus.

Hackett CJ, Eisenlohr LC. Hackett CJ, et al. Immunol Res. 1990;9(2):103-14. doi: 10.1007/BF02918201. Immunol Res. 1990. PMID: 2140852 Review.

9

Integrating safety and efficacy evaluation throughout vaccine research and development.

Curlin G, Landry S, Bernstein J, Gorman RL, Mulach B, Hackett CJ, Foster S, Miers SE, Strickler-Dinglasan P. Curlin G, et al. Among authors: hackett cj. Pediatrics. 2011 May;127 Suppl 1(Suppl 1):S9-15. doi: 10.1542/peds.2010-1722C. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502246 Free PMC article. No abstract available.

10

Some epidemiological aspects of yaws eradication.

HACKETT CJ. HACKETT CJ. Bull World Health Organ. 1960;23(6):739-61. Bull World Health Organ. 1960. PMID: 13710280 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results